Protein kinase D1 conditional null mice show minimal bone loss following ovariectomy. (15th October 2018)
- Record Type:
- Journal Article
- Title:
- Protein kinase D1 conditional null mice show minimal bone loss following ovariectomy. (15th October 2018)
- Main Title:
- Protein kinase D1 conditional null mice show minimal bone loss following ovariectomy
- Authors:
- Bollag, Wendy B.
Ding, Ke-Hong
Choudhary, Vivek
Xu, Jianrui
Zhong, Qing
Elsayed, Ranya
Bailey, Lakiea J.
Elsalanty, Mohammed
Yu, Kanglun
Johnson, Maribeth H.
McGee-Lawrence, Meghan E.
Isales, Carlos M. - Abstract:
- Abstract: We previously found that 3- and 6-month-old male mice with conditional ablation of protein kinase D1 (PRKD1) in osteoprogenitor cells (expressing Osterix) exhibited reduced bone mass. Others have demonstrated similar effects in young female PRKD1-deficient mice. Here we examined the bone resorptive response of adult female floxed control and conditional knockout (cKO) mice undergoing sham surgery or ovariectomy (OVX). Femoral and tibial bone mineral density (BMD) values were significantly reduced upon OVX in control, but not cKO, females compared to the respective sham-operated mice. Micro-CT analysis showed that OVX significantly increased trabecular number and decreased trabecular spacing in cKO but not control mice. Finally, in control mice serum levels of a marker of bone resorption (pyridinoline crosslinks) and the osteoclast activator RANKL significantly increased upon OVX; however, no such OVX-induced increase was observed in cKO mice. Our results suggest the potential importance of PRKD1 in response to estrogen loss in bone. Highlights: Floxed control and protein kinase D1 conditional knockout (cKO) mice were examined. Ovariectomy (OVX) decreased bone mineral density in control but not cKO mice. OVX elevated serum levels of a bone resorption marker in control but not cKO mice. OVX increased serum levels of an osteoclast activator in control but not cKO mice. Protein kinase D1 likely plays a role in bone responses to estrogen and its loss.
- Is Part Of:
- Molecular and cellular endocrinology. Volume 474(2018)
- Journal:
- Molecular and cellular endocrinology
- Issue:
- Volume 474(2018)
- Issue Display:
- Volume 474, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 474
- Issue:
- 2018
- Issue Sort Value:
- 2018-0474-2018-0000
- Page Start:
- 176
- Page End:
- 183
- Publication Date:
- 2018-10-15
- Subjects:
- Bone mass -- Osteopenia -- Osteoporosis -- Protein kinase D1 (PRKD1) -- Pyridinoline crosslinks (PYD) -- Receptor activator of nuclear factor kappa-B ligand (RANKL)
Endocrinology -- Periodicals
Molecular biology -- Periodicals
Cytology -- Periodicals
Endocrinology -- Periodicals
Hormones -- Periodicals
Endocrinologie -- Périodiques
Cytology
Endocrinology
Molecular biology
Periodicals
573.4 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03037207 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.mce.2018.03.006 ↗
- Languages:
- English
- ISSNs:
- 0303-7207
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.760000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7093.xml